Efficacy of Noninvasive Ventilation With Expiratory Washout in Stable COPD Patients
Respiratory Care · 2025
DOI: 10.1089/respcare.11876 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Respiratory Care, 2025. Verfasst von Stacey Kung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ms. Kung, Dr. Ruth Semprini, and Ms Eathorne are affiliated with Medical Research Institute of New Zealand, Wellington, New Zealand. Hauptthemen laut MEDLINE: Noninvasive Ventilation, Pulmonary Disease, Chronic Obstructive, Masks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
Background
A noninvasive ventilation (NIV) mask has been designed to deliver NIV with expiratory washout to improve efficacy of ventilation by optimizing clearance of expired gases from the anatomic dead space. This study compared the performance and comfort of a novel investigational mask with expiratory washout with a conventional mask during NIV therapy.
Methods
In this pilot crossover study, participants with severe stable COPD attended a single visit to receive bi-level NIV through 2 masks; the investigational mask with expiratory washout and a conventional mask. The order of mask use was randomly allocated, and each mask was used for 60 min with a 30-60-min washout in between. The primary outcome was transcutaneous carbon dioxide at 60 min. Other physiologic and NIV device variables were also assessed.
Results
The mean difference (95% CI) in the transcutaneous carbon dioxide between the investigational and conventional masks at 60 min, adjusted for baseline, was -0.74 mm Hg, 95% CI -2.81 to 1.33 mm Hg (P = .45). The investigational mask with expiratory washout elicited a lower tidal volume (-128.7 mL, 95% CI -190.0 to -67.3 mL; P < .001) and minute ventilation (-2.28 L/min,, 95% CI -3.12 to -1.43 L/min; P < .001), and a higher leak (7.96 L/min, 95% CI 4.39-11.54 L/min; P < .001) than the conventional mask. There were no differences in other physiologic responses or ratings of dyspnea or comfort.
Conclusions
NIV therapy delivered by using a novel mask with expiratory washout was similarly effective at reducing transcutaneous carbon dioxide, whereas the delivered tidal volume and minute ventilation were significantly lower when compared with a conventional mask in participants with severe COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ms. Kung, Dr. Ruth Semprini, and Ms Eathorne are affiliated with Medical Research Institute of New Zealand, Wellington, New Zealand.
- Drs. Alex Semprini, Kirton, and Beasley are affiliated with Medical Research Institute of New Zealand, Wellington, New Zealand; and Victoria University Wellington, Wellington, New Zealand.
- Ms. Fogarin and Mr. Zoellner are affiliated with Fisher & Paykel Healthcare, Auckland, New Zealand.
Zitieren
APA
Kung, S., Semprini, A. C., Kirton, L. W., Fogarin, J. R., Zoellner, S. K., Beasley, R., Eathorne, A., & Semprini, R. A. C. (2025). Efficacy of Noninvasive Ventilation With Expiratory Washout in Stable COPD Patients. Respiratory Care. https://doi.org/10.1089/respcare.11876
Vancouver
Kung S, Semprini AC, Kirton LW, Fogarin JR, Zoellner SK, Beasley R, et al. Efficacy of Noninvasive Ventilation With Expiratory Washout in Stable COPD Patients. Respiratory Care. 2025. doi:10.1089/respcare.11876
BibTeX
@article{Kung2025,
author = {Kung, Stacey and Semprini, Alex C and Kirton, Louis W and Fogarin, Jess R and Zoellner, Sascha K and Beasley, Richard and Eathorne, Allie and Semprini, Ruth A C},
title = {Efficacy of Noninvasive Ventilation With Expiratory Washout in Stable COPD Patients},
journal = {Respiratory Care},
year = {2025},
doi = {10.1089/respcare.11876}
}
EUVIMED